Callan Capital, LLC - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 100 filers reported holding INFINITY PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.0%.

Quarter-by-quarter ownership
Callan Capital, LLC ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$33,364
+31.6%
158,5000.0%0.00%
+33.3%
Q1 2023$25,360
-71.2%
158,5000.0%0.00%
-72.7%
Q4 2022$87,968
-73.3%
158,500
+8.4%
0.01%
-77.1%
Q4 2021$329,000
-34.2%
146,2000.0%0.05%
-42.2%
Q3 2021$500,000
+37.4%
146,200
+20.0%
0.08%
+31.7%
Q2 2021$364,000
+134.8%
121,800
+66.4%
0.06%
+96.9%
Q4 2020$155,00073,2000.03%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
BVF INC/IL 6,353,645$7,561,0000.31%
SPHERA FUNDS MANAGEMENT LTD. 1,476,000$1,756,0000.24%
EAM Investors, LLC 840,556$1,000,0000.22%
Gratus Capital, LLC 1,249,248$1,487,0000.16%
Ally Bridge Group (NY) LLC 86,242$103,0000.07%
MARINER INDEPENDENT ADVISOR NETWORK, LLC 1,252,822$1,491,0000.06%
Bleichroeder LP 250,000$298,0000.06%
GSA CAPITAL PARTNERS LLP 324,784$386,0000.05%
Polar Capital Holdings Plc 5,000,000$5,950,0000.04%
PLATINUM INVESTMENT MANAGEMENT LTD 545,508$649,0000.03%
View complete list of INFINITY PHARMACEUTICALS INC shareholders